Afsal Mohammed Kadavilpparampu Mohamed
About Afsal Mohammed Kadavilpparampu Mohamed
Data last updated:
Afsal Mohammed Kadavilpparampu Mohamed is a Director at Esente Healthcare Private Limited (since 2014), Director at B.Well-Nulife Medical Center Private Limited (since 2022) and Director at Esente Innovations & Research Solutions Private Limited (since 2023). The companies operate in Pharma and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹50.58 Cr; the largest is Esente Healthcare Private Limited at ₹48.39 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Esente Healthcare Private Limited U24230KA2014PTC077890 | Director | 23 Dec 2014 | 2014 | ₹48.39 Cr (FY 2025) | Active |
 B.Well-Nulife Medical Center Private Limited U85100KL2022PTC074237 | Director | 25 Feb 2022 | 2022 | ₹1.99 Cr (FY 2025) | Active |
| Esente Innovations & Research Solutions Private Limited U21000KA2023PTC182885 | Director | 29 Dec 2023 | 2023 | ₹19.8 Lakh (FY 2025) | Active |
Board colleagues of Afsal Mohammed Kadavilpparampu Mohamed
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Afsal Mohammed Kadavilpparampu Mohamed
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Afsal Mohammed Kadavilpparampu Mohamed
Afsal Mohammed Kadavilpparampu Mohamed currently holds 3 directorships: Esente Healthcare Private Limited (Director, since 23 Dec 2014, revenue ₹48.39 Cr (FY 2025)); B.Well-Nulife Medical Center Private Limited (Director, since 25 Feb 2022, revenue ₹1.99 Cr (FY 2025)); Esente Innovations & Research Solutions Private Limited (Director, since 29 Dec 2023, revenue ₹19.8 Lakh (FY 2025)).
Afsal Mohammed Kadavilpparampu Mohamed was first appointed on 23 Dec 2014 as Director at Esente Healthcare Private Limited. The most recent appointment on record is 29 Dec 2023 at Esente Innovations & Research Solutions Private Limited.
The 3 current companies of Afsal Mohammed Kadavilpparampu Mohamed that report revenue have a combined latest revenue of ₹50.58 Cr: Esente Healthcare Private Limited ₹48.39 Cr (FY 2025); B.Well-Nulife Medical Center Private Limited ₹1.99 Cr (FY 2025); Esente Innovations & Research Solutions Private Limited ₹19.8 Lakh (FY 2025).
The current boards of Afsal Mohammed Kadavilpparampu Mohamed's companies include Arackal Nelliserry Antony Varghese (Esente Healthcare Private Limited), Muraleedharan Ajithkumar (Esente Healthcare Private Limited), Prathap Madhavan Pillai (Esente Healthcare Private Limited), Baker Ansari (B.Well-Nulife Medical Center Private Limited), Muthirapparambil Dasan Sumesh (B.Well-Nulife Medical Center Private Limited), Pulikkal Rahim Wasim Raja (B.Well-Nulife Medical Center Private Limited), among others.